|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 12/29/15 Anavex Life Sciences Corp. 10-K 9/30/15 73:5M S2 Filings LLC/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 573K
2: EX-10.91 Material Contract HTML 124K
3: EX-10.92 Material Contract HTML 79K
4: EX-23.1 Consent of Experts or Counsel HTML 19K
5: EX-31.1 Certification -- §302 - SOA'02 HTML 28K
6: EX-31.2 Certification -- §302 - SOA'02 HTML 27K
7: EX-32.1 Certification -- §906 - SOA'02 HTML 22K
14: R1 Document and Entity Information HTML 50K
15: R2 Consolidated Balance Sheets HTML 68K
16: R3 Consolidated Balance Sheets (Parenthetical) HTML 30K
17: R4 Consolidated Statements of Operations HTML 68K
18: R5 Consolidated Statements of Cash Flows HTML 93K
19: R6 Consolidated Statement of Changes in Stockholders' HTML 112K
Equity
20: R7 Consolidated Statement of Changes in Stockholders' HTML 33K
Equity (Parenthetical)
21: R8 Business Description and Basis of Presentation HTML 28K
22: R9 Summary of Significant Accounting Policies HTML 95K
23: R10 Equipment HTML 36K
24: R11 Promissory Notes Payable HTML 37K
25: R12 Deferred Grant Income HTML 25K
26: R13 Non-interest Bearing Liabilities HTML 86K
27: R14 Capital Stock HTML 39K
28: R15 Lincoln Park Purchase Agreement HTML 33K
29: R16 Related Party Transactions HTML 36K
30: R17 Commitments HTML 105K
31: R18 Income Taxes HTML 54K
32: R19 Supplemental Cash Flow Information HTML 29K
33: R20 Subsequent Events HTML 27K
34: R21 Summary of Significant Accounting Policies HTML 123K
(Policies)
35: R22 Summary of Significant Accounting Policies HTML 38K
(Tables)
36: R23 Equipment (Tables) HTML 33K
37: R24 Promissory Notes Payable (Tables) HTML 30K
38: R25 Non-interest Bearing Liabilities (Tables) HTML 76K
39: R26 Commitments (Tables) HTML 103K
40: R27 Income Taxes (Tables) HTML 51K
41: R28 Business Description and Basis of Presentation HTML 28K
(Details Narrative)
42: R29 Summary of Significant Accounting Policies HTML 31K
(Details Narrative)
43: R30 Summary of Significant Accounting Policies HTML 31K
(Details)
44: R31 Summary of Significant Accounting Policies HTML 36K
(Details 1)
45: R32 Equipment (Details) HTML 31K
46: R33 Promissory Notes Payable (Details Narrative) HTML 43K
47: R34 Promissory Notes Payable (Details) HTML 43K
48: R35 Deferred Grant Income (Details Narrative) HTML 24K
49: R36 Non-interest Bearing Liabilities (Details HTML 110K
Narrative)
50: R37 Non-interest Bearing Liabilities (Details) HTML 25K
51: R38 Non-interest Bearing Liabilities (Details 1) HTML 33K
52: R39 Non-interest Bearing Liabilities (Details 2) HTML 35K
53: R40 Non-interest Bearing Liabilities (Details 3) HTML 37K
54: R41 Non-interest Bearing Liabilities (Details 4) HTML 32K
55: R42 Non-interest Bearing Liabilities (Details 5) HTML 32K
56: R43 Non-interest Bearing Liabilities (Details 6) HTML 31K
57: R44 Capital Stock (Details Narrative) HTML 96K
58: R45 Lincoln Park Purchase Agreement (Details HTML 48K
Narrative)
59: R46 Related Party Transactions (Details Narrative) HTML 68K
60: R47 Commitments (Details Narrative) HTML 54K
61: R48 Commitments (Details Narrative 1) HTML 50K
62: R49 Commitments (Details) HTML 44K
63: R50 Commitments (Details 1) HTML 40K
64: R51 Commitments (Details 2) HTML 47K
65: R52 Commitments (Details 3) HTML 78K
66: R53 Income Taxes (Details Narrative) HTML 24K
67: R54 Income Taxes (Details) HTML 43K
68: R55 Income Taxes (Details 1) HTML 50K
69: R56 Supplemental Cash Flow Information (Details HTML 40K
Narrative)
70: R57 Subsequent Events (Details Narrative) HTML 32K
72: XML IDEA XML File -- Filing Summary XML 126K
71: EXCEL IDEA Workbook of Financial Reports XLSX 81K
8: EX-101.INS XBRL Instance -- avxl-20150930 XML 1.42M
10: EX-101.CAL XBRL Calculations -- avxl-20150930_cal XML 130K
11: EX-101.DEF XBRL Definitions -- avxl-20150930_def XML 590K
12: EX-101.LAB XBRL Labels -- avxl-20150930_lab XML 946K
13: EX-101.PRE XBRL Presentations -- avxl-20150930_pre XML 787K
9: EX-101.SCH XBRL Schema -- avxl-20150930 XSD 168K
73: ZIP XBRL Zipped Folder -- 0001615774-15-003756-xbrl Zip 128K
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Board of Directors and Stockholders
Anavex Life Sciences Corp.
New York, New York
We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 (No. 333-207600) of Anavex Life Sciences Corp. of our report dated December 29, 2015, relating to the consolidated financial statements which appear in this Form 10-K.
/s/ BDO USA, LLP
C:
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 12/29/15 | |||
| For Period end: | 9/30/15 | 4/A, 5 | ||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/27/23 Anavex Life Sciences Corp. 10-K 9/30/23 54:5.7M Electro Filings LLC/FA 1/27/23 Anavex Life Sciences Corp. 10-K/A 9/30/22 4:308K Electro Filings LLC/FA 11/28/22 Anavex Life Sciences Corp. 10-K 9/30/22 49:5.1M Electro Filings LLC/FA 11/24/21 Anavex Life Sciences Corp. 10-K 9/30/21 50:13M Electro Filings LLC/FA 12/28/20 Anavex Life Sciences Corp. 10-K 9/30/20 44:3.6M Electro Filings LLC/FA |